Login / Signup

Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.

Erin K BarrArlene NaranjoClare J TwistSheena C TenneyMary Lou SchmidtWendy B LondonJulie Gastier-FosterE Stanton AdkinsPeter MatteiMichael H HandlerKatherine K MatthayJulie R ParkJohn M MarisAmi V DesaiSusan L Cohn
Published in: Pediatric blood & cancer (2024)
The ANBL0531 trial treatment algorithm resulted in excellent long-term survival. More effective treatments are needed for subsets of patients with unfavorable biology tumors.
Keyphrases
  • young adults
  • machine learning
  • clinical trial
  • palliative care
  • phase iii
  • deep learning
  • peripheral blood
  • phase ii
  • randomized controlled trial
  • stem cells
  • replacement therapy
  • mesenchymal stem cells
  • neural network